Yeast-based immunotherapy against Clostridium difficile infection
US-12384833-B2 · Aug 12, 2025 · US
This page is not indexed by search engines while we improve data quality.
Chen Kevin — Human Necessities
Chen Kevin holds 4 patents in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Chen Kevin |
| Technology | Human Necessities |
| Patents in slice | 4 |
| Recent patents in slice | 2 |
| First year | 2018 |
| Last year | 2025 |
Representative patents
Notable publications linking Chen Kevin to Human Necessities.
Yeast-based immunotherapy against Clostridium difficile infection
US-12384833-B2 · Aug 12, 2025 · US
Yeast-based immunotherapy against Clostridium difficile infection
US-12384833-B2 · Aug 12, 2025 · US
Yeast-based immunotherapy against Clostridium difficile infection
US-12384833-B2 · Aug 12, 2025 · US
Yeast-based immunotherapy against Clostridium difficile infection
US-12384833-B2 · Aug 12, 2025 · US
Recent filings
Latest patents from Chen Kevin in Human Necessities.
Yeast-based immunotherapy against Clostridium difficile infection
US-12384833-B2 · Aug 12, 2025 · US
Yeast-based immunotherapy against Clostridium difficile infection
US-12384833-B2 · Aug 12, 2025 · US
Yeast-based immunotherapy against Clostridium difficile infection
US-12384833-B2 · Aug 12, 2025 · US
Yeast-based immunotherapy against Clostridium difficile infection
US-12384833-B2 · Aug 12, 2025 · US
Yeast-based immunotherapy against Clostridium difficile infection
US-12384833-B2 · Aug 12, 2025 · US
Related pages
Navigate to parent entity pages.